´ëÇѺÎÀÎÁ¾¾çÇÐȸ The 6th Biennial Meeting of Asian Society ofGynecologic Oncology (ASGO 2019), 25th Annual Symposium of KSGO 2019 : 2019-10-10±³À°ÀÏÀÚ : 2019-10-10
±³À°Àå¼Ò : ¼Ûµµ ÄÁº¥½Ã¾Æ ½Å°ü ±×·£µåº¼·ë ¹× ¼ÒȸÀǽÇ
±³À°ÁÖÁ¦ :
The 6th Biennial Meeting of Asian Society ofGynecologic Oncology (ASGO 2019), 25th Annual Symposium of KSGO 2019ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ±è¹ÎÇý
¿¬¶ôó : 02-3452-1855
À̸ÞÀÏ :
asgo2019@aim-korea.com ±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ÀÎõ±¤¿ª½Ã±³À°½Ã°£ : 27 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í (ÇöÀåµî·Ïºñ ±âÁØ) ºÎÀÎÁ¾¾ç°ú/ Ÿ°ú Àü¹®ÀÇ/ Á¦¾à»ç ´ã´çÁ÷¿ø: 500,000¿ø ÀüÀÓÀÇ/¼ö·ÃÀÇ: 400,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-10 GBR A 08:30~08:45 Immune checkpoint inhibitors in gynecologic oncology Kyung-Jin Min(Korea University)
±³À°½Ã°£ 10-10 GBR A 08:45~09:00 Companion diagnostics and clinical biomarkers Chel Hun Choi(Sungkyunkwan University)
±³À°½Ã°£ 10-10 GBR A 09:00~09:15 Criteria of assessment with Imaging: iRECIST, irRECIST, irRC, RECIST1.1 Hyun Jin Choi(Chung-Ang University)
±³À°½Ã°£ 10-10 GBR A 09:15~09:30 Management of IO agent adverse events So Jin Shin(Keimyung University)
±³À°½Ã°£ 10-10 GBR A 10:20~10:40 Management of PARPi adverse events Robert Coleman(University of Texas)
±³À°½Ã°£ 10-10 GBR A 10:40~11:00 Endometriosis-associated ovarian cancer: a challenging disease Yutaka Osuga(University of Tokyo)
±³À°½Ã°£ 10-10 GBR A 11:00~11:20 Laparoscopic fertility-sparing surgery for early-stage ovarian cancer Yang Xiang(Peking Union Medical College Hospital)
±³À°½Ã°£ 10-10 GBR A 11:20~11:40 The role of lymphadenectomy in ovarian cancer - post LIONem Andreas du Bois(Kliniken Essen-Mitte)
±³À°½Ã°£ 10-10 GBR A 12:30~12:50 Evolving of BRCA mutated ovarian cancer treatment: study 19 Richard Penson(Massachusetts General Hospital)
±³À°½Ã°£ 10-10 GBR A 13:40~14:10 Toward precision medicine: evolution of global distributed research network in Korea Rae-Woong Park(Ajou University School of Medicine)
±³À°½Ã°£ 10-10 GBR A 14:10~14:40 Artificial Intelligence in medicine Yoon-Sup Choi(Digital Healthcare Institute)
±³À°½Ã°£ 10-10 GBR B 15:00~15:15 Ovarian clear cell carcinoma Wen-Yee Chay(National Cancer Centre Singapore)
±³À°½Ã°£ 10-10 GBR B 15:15~15:30 Uterine leiomyosarcoma E Sun Paik(Samsung Medical Center)
±³À°½Ã°£ 10-10 GBR B 15:30~15:45 Trophoblastic disease update Yang Xiang(Peking Union Medical College Hospital)
±³À°½Ã°£ 10-10 GBR B 15:45~16:00 Germ cell tumor Hiroyuki Fujiwara(Jichi Medical University)
±³À°½Ã°£ 10-10 GBR B 16:00~16:15 Low grade serous carcinoma Miseon Kim(CHA University School of Medicine)
±³À°½Ã°£ 10-10 204-205 15:00~15:20 Locally advanced cervical cancer with lymph node positive on image: Chemoradiation first? Hyun-Cheol Kang(Seoul National University Hospital)
±³À°½Ã°£ 10-10 204-205 15:20~15:40 What is the best sequence of chemotherapy and radiotherapy in locoregionally advanced endometrial cancer? Jihye Cha(Yonsei University Wonju College of Medicine)
±³À°½Ã°£ 10-10 204-205 15:40~16:00 The role of brachytherapy in the treatment of cervical cancer Chomporn Sitathanee(Mahidol University)
±³À°½Ã°£ 10-10 204-205 16:00~16:20 MRI-guided brachytherapy in cervical cancer in Korea Yeon Joo Kim(National Cancer Center)
±³À°½Ã°£ 10-10 206-207 15:00~15:10 Identification of key genes and microRNAs in cervical cancer progression by integrated bioinformatics analysis Yuqin Zang(Tianjin Medical University General Hospital)
±³À°½Ã°£ 10-10 206-207 15:10~15:20 The distribution and prevalence of high-risk human papillomavirus of women in western China: A meta-analysis Mengpei Zhang(West China Second University Hospital, Sichuan University)
±³À°½Ã°£ 10-10 206-207 15:20~15:30 Differences in the results of evaluation of quality assurance between the two methods of provision of population-based cervical cancer screening in Japan Eiko Aoki(International University of Health and Welfare,Mita Hospital)
±³À°½Ã°£ 10-10 206-207 15:30~15:40 A prospective randomized controlled study to compare thermal ablation with cryotherapy in cervical cancer screening Dipanwita Banerjee(Chittaranjan National Cancer Institute)
±³À°½Ã°£ 10-10 206-207 15:40~15:50 Application of TERC and P16 FISH in triage of ASCUS Ying Li(Women)
±³À°½Ã°£ 10-10 206-207 15:50~16:00 Risk factors for type-specific persistence of human papillomavirus and recurrence of cervical intraepithelial neoplasia after conization Yung-Taek Ouh(Korea University Guro Hospital)
±³À°½Ã°£ 10-10 206-207 16:00~16:10 Abnormal endocervical curettage (ECC) result is an independent risk factor of positive margins in conization specimen. Jian AN(Fujian Provincial Maternity and Children¡¯s Hospital)
±³À°½Ã°£ 10-10 206-207 16:10~16:20 GX-188E, a therapeutic HPV vaccine, in combination with imiquimod or IL-7-HYFC for treatment of HPV-16 or HPV-18 related cin 3: results from phase 2 study Sung Jong Lee(Seoul St. Mary¡¯s Hospital)
±³À°½Ã°£ 10-10 206-207 16:20~16:30 Quality assessment of websites providing information on HPV vaccines in Thailand Naratassapol Likitdee(Khon Kaen University)
±³À°½Ã°£ 10-10 GBR B 16:50~17:05 The distribution and prevalence of human papillomavirus in women in mainland China Rutie Yin(West China Second University Hospital of Sichuan University)
±³À°½Ã°£ 10-10 GBR B 17:05~17:20 Korean national cervical cancer screening program Mina Suh(Korea Cancer Center)
±³À°½Ã°£ 10-10 GBR B 17:20~17:35 Japanese population-based cervical cancer management system Kumiko Saika(National Cancer Center, Japan)
±³À°½Ã°£ 10-10 GBR B 17:35~17:50 Cervical cancer screening in India Seema Singhal(All India Institute of Medical Sciences)
±³À°½Ã°£ 10-10 GBR B 17:50~18:05 Cervical cancer screening in Myanmar Myint Myint Thinn(Central Women¡¯s Hospital)
±³À°½Ã°£ 10-10 204-205 16:50~17:10 Squamous cell carcinoma of the vulva and its precursors: does p53/p16 status matter? Kyu-Rae Kim(University of Ulsan College of Medicine, Asan Medical Center)
±³À°½Ã°£ 10-10 204-205 17:10~17:30 Mucinous ovarian tumor and pseudomyxoma Chong Woo Yoo(National Cancer Center)
±³À°½Ã°£ 10-10 204-205 17:30~17:50 Molecular pathology and immunohistochemistry of gynecologic malignancy Daichi Maeda(Osaka University)
±³À°½Ã°£ 10-10 204-205 17:50~18:10 Pathology of ovarian cancer precursors Ren-Chin Wu(Chang Gung Memorial Hospital)
±³À°½Ã°£ 10-10 206-207 16:50~17:00 Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: A Korean Gynecologic Oncology Group Study Mi Kyoung Kim(CHA Gangnam Medical Center, CHA University)
±³À°½Ã°£ 10-10 206-207 17:00~17:10 Diagnostic accuracy of MPap¢â in women with abnormal uterine bleeding for endometrial cancer: preliminary report of a multicenter validating confirmatory study Hung-Cheng Lai(Shuang Ho Hospital, Taipei Medical University)
±³À°½Ã°£ 10-10 206-207 17:10~17:20 GnRH-I antagonist Cetrorelix can increase the response of endometrial cancer cells to megestrol acetate Lijun Zhao(Peking University People¡¯s Hospital)
±³À°½Ã°£ 10-10 206-207 17:20~17:30 The effect of combined progesterone and GnRH agonist on the growth of endometrial cancer cells Kyungjoo Cho(School of Medicine, Gachon University, Gil Medical Center)
±³À°½Ã°£ 10-10 206-207 17:30~17:40 Effect of Megestrol Acetate plus Metformin as Fertility-Sparing Treatment for Patients with Atypical Endometrial Hyperplasia and Well-differentiated Endometrial Cancer. A Randomized Controlled Trial Jun Guan(Shanghai OBGYN Hospital of Fudan University)
±³À°½Ã°£ 10-10 206-207 17:40~17:50 The oncologic outcome after long term fertility-sparing hormonal management for early stage endometrioid endometrial cancer Su Hyun Chae(Konkuk Medical Center)
±³À°½Ã°£ 10-10 206-207 17:50~18:00 Prolactin enhances the proliferation of endometrial glandular cells and endometrial cancer cells in conjunction with estradiol via regulation of prolactin receptor and estrogen receptor Munekage Yamaguchi(Kumamoto University)
±³À°½Ã°£ 10-10 206-207 18:00~18:10 Selecting endometrial cancer patients for high risk of recurrence Ming-Yin Lin(Peter MacCallum Cancer Centre)
±³À°½Ã°£ 10-10 206-207 18:10~18:20 Using deep learning with convolutional neural network approach to identify the invasion depth of myometrium under MR images in early stage of endometrial cancer ~ a pilot study of TSGH in Taiwan Cheng-Chang Chang(Tri-Service General Hospital, National Defense Medical Center)
±³À°½Ã°£ 10-10 GBR B 16:50~17:10 Elimination of cervical cancer: Global overview and prospects for Asia Neerja Bhatla(All India Institute of Medical Sciences)
±³À°½Ã°£ 10-10 GBR B 17:10~17:30 VIA with Picture as One Option Strategy in Increasing the Cervical Cancer Screening Coverage in Low Resource Setting area Dwiana Ocviyanti(Universitas Indonesia AOGIN)
±³À°½Ã°£ 10-10 GBR B 17:30~17:50 HPV test as a primary cervical cancer screening Warner Huh(University of Alabama at Birmingham)
±³À°½Ã°£ 10-10 GBR B 17:50~18:10 Cost-effectiveness of primary HPV test and triage test in cervical cancer screening Wichai Termrungruanglert(Chulalongkorn University)
±³À°½Ã°£ 10-10 GBR A 08:30~08:45 Role of GCIG on changing the practice in gynecologic cancer patients Keiichi Fujiwara(Saitama Medical University International Medical Center)
±³À°½Ã°£ 10-10 GBR A 08:45~09:00 Operation and harmonization for international clinical trial management Yusuke Kajimoto(GOTIC (Gynecologic Oncology Trial and Investigation Consortium of North Kanto))
±³À°½Ã°£ 10-10 GBR A 09:00~09:15 Cervix & CCRN Sang-Young Ryu(Korea Cancer Center Hospital)
±³À°½Ã°£ 10-10 GBR A 09:15~09:30 Ovarian Cancer Rongyu Zang(Fudan University Zhongshan Hospital)
±³À°½Ã°£ 10-10 GBR A 09:30~09:45 Endometrial Cancer Jae-Weon Kim(Seoul National University)
±³À°½Ã°£ 10-10 206-207 08:30~08:40 Development and preclinical testing of Patient-derived xenograft(PDX) models for uterine cancer Soo Young Jeong(Samsung Medical Center)
±³À°½Ã°£ 10-10 206-207 08:40~08:50 LncRNA RP11-395G23.3, as a competitive endogenous RNA, regulate PTEN expression by sponging miR-205-5p in the progression of Endometrial Cancer Weijuan Xin(Obstetrics and Gynecology Hospital of Fudan University)
±³À°½Ã°£ 10-10 206-207 08:50~09:00 Calcium Channel Cav1.3 Participates in Epithelial-Mesenchymal Transition of Endometrial Cancer Cells Induced by Transforming Growth Factor ¥â Yibo Dai(Peking University People)
±³À°½Ã°£ 10-10 206-207 09:00~09:10 Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers Jeong-Won Lee(Samsung Medical Center)
±³À°½Ã°£ 10-10 206-207 09:10~09:20 Genomic comparison of endometrioid endometrial carcinoma and its precancerous lesions Yao Wang(Peking Union Medical College Hospital)
±³À°½Ã°£ 10-10 206-207 09:20~09:30 Clinicopathologic significance of mismatch repair protein expression in endometrial cancer Mi-Kyung Kim(Ewha Womans University)
±³À°½Ã°£ 10-10 206-207 09:30~09:40 Long Term Outcome of Young Patients with Mismatch-Repair Deficient Endometrial Carcinoma Mandy Man Yee Chu(Queen Mary Hospital, The University of Hong Kong)
±³À°½Ã°£ 10-10 206-207 09:40~09:50 Mutation Landscape of Germline and Somatic BRCA1/2 genes in High-Grade Serous Ovarian Cancer Patients Kyung Jin Eoh(Yonsei University College of Medicine)
±³À°½Ã°£ 10-10 206-207 09:50~10:00 Hormone Replacement Therapy After Premature Surgical Menopause and Health Services Utilization Ji-Hyun Jang(The University of British Columbia)
±³À°½Ã°£ 10-10 204-205 08:30~08:50 Selected poster discussion: merits and demerits Yoo-Young Lee(Samsung Medical Center)
±³À°½Ã°£ 10-10 204-205 09:00~09:15 Radical hysterectomy Dae-Yeon Kim(Asan Medical Center University of Ulsan)
±³À°½Ã°£ 10-10 204-205 09:15~09:30 LEER Hee-Seung Kim(Seoul National University College of Medicine)
±³À°½Ã°£ 10-10 204-205 09:30~09:45 TMMR for cervical cancer Rainer Kimmig(University Hospital Essen)
±³À°½Ã°£ 10-10 204-205 09:45~10:00 PMMR for endometrial cancer Rainer Kimmig(University Hospital Essen)
±³À°½Ã°£ 10-10 GBR A 10:20~10:35 Overview of the current status of clinical trials in Asia Kosei Hasegawa(Saitama Medical University International Medical Center)
±³À°½Ã°£ 10-10 206-207 10:20~10:30 Ovarian metastasis in early-stage cervical cancer: a large single institution study Kittipat Charoenkwan(Chiang Mai University)
±³À°½Ã°£ 10-10 206-207 10:30~10:40 Clinical pathological analysis and prognosis prediction model of small cell carcinoma of the cervix Chunyin Wei(Guangxi Medical University)
±³À°½Ã°£ 10-10 206-207 10:40~10:50 Impact of learning curve on the survival of abdominal or minimally invasive radical hysterectomy for early stage cervical cancer Hwajung Lee(Yonsei University College of Medicine)
±³À°½Ã°£ 10-10 206-207 10:50~11:00 Impact of obesity on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy with pelvic node dissection Kittinun Leetanaporn(Prince of Songkhla University)
±³À°½Ã°£ 10-10 206-207 11:00~11:10 Indications of prophylactic extended-field irradiation for patients with cervical cancer Weiping Wang(Peking Union Medical College Hospital)
±³À°½Ã°£ 10-10 206-207 11:10~11:20 Post-irradiation PD-L1 expression predicts better prognosis after carbon ion radiotherapy in uterine cervical adenocarcinoma Moito Iijima(Keio University School of Medicine)
±³À°½Ã°£ 10-10 206-207 11:20~11:30 Comparisons of Radiotherapy Outcomes in Cervical Squamous Cell Carcinoma Stage IIIB with and without Lymph Node Enlargement Fitriyadi Kusuma(Faculty of Medicine Universitas Indonesia)
±³À°½Ã°£ 10-10 206-207 11:30~11:40 Clinical significance of centralized surveillance of hydatidiform mole: five years Lan-zhou Jiao(Dalian Medical University)
±³À°½Ã°£ 10-10 206-207 11:40~11:50 Gestational trophoblastic neoplasia: Determinants of outcome Seema Singhal(All India Institute of Medical Sciences)
±³À°½Ã°£ 10-10 204-205 10:20~10:29 Total pelvic peritonectomy for ovarian cancer with extensive peritoneal carcinomatosis in pelvic cavity Libing Xiang(Fudan University Shanghai Cancer Center)
±³À°½Ã°£ 10-10 204-205 10:29~10:38 Clinical anatomy required in identifying pelvic autonomic nerve system Yasuhiko Shiki(Osaka Rosai Hospital)
±³À°½Ã°£ 10-10 204-205 10:38~10:47 Single-port laparoscopic radical trachelectomy with fluorescent image-guided sentinel lymph node dissection Sang Wun Kim(Yonsei Cancer Center)
±³À°½Ã°£ 10-10 204-205 10:47~10:56 Prevention of Chylous ascites during the Robot assisted transperitoneal infrarenal paraaortic lymphadenectomy Yoon Hee Lee(Kuyngpook national university Chilgok hospital)
±³À°½Ã°£ 10-10 204-205 10:56~11:05 Laparoscopic primary repair of duodenal perforation after laparoscopic para-aortic lymphadenectomy Hyeon Myeong Hong(Hanyang University College of Medicine)
±³À°½Ã°£ 10-10 204-205 11:05~11:14 Robotic anterior exenteration for recurrent cervical cancer Rupinder Sekhon(RGCIRC, Delhi)
±³À°½Ã°£ 10-10 204-205 11:14~11:23 Laparoscopic extraperitoneal systematic pelvic and PARA-aortic lymphadenectomy Supachai Raungkaewmanee(National Cancer Institute)
±³À°½Ã°£ 10-10 204-205 11:23~11:32 Nerve sparing modified laparoscopic radical hysterectomy with vaginal cuff closure and without uterine manipulator Dae-yeon Kim(Asan Medical Center University of Ulsan)
±³À°½Ã°£ 10-10 204-205 11:32~11:41 Single-site robotic staging surgery for early stage ovarian cancer Ji Geun Yoo(Seoul St. Mary)
±³À°½Ã°£ 10-10 204-205 11:41~11:50 Combined technique of single-site robot and laparoscopy in comprehensive staging operation of endometrial cancer Bo-Ra Lee(Chung-Ang University Hospital)
±³À°½Ã°£ 10-10 204-205 11:10~11:25 The Role of the CRC in an Investigator Initiated Trial Ju Yeon Yi()
±³À°½Ã°£ 10-10 204-205 11:25~11:40 The role and environment of Research Nurse Noriko Fujiwara(The Institute of Medical Science, The University of Tokyo)
±³À°½Ã°£ 10-10 204-205 11:40~11:55 How to start Investigator-initiated study? Jung-Yun Lee(Yonsei University)
±³À°½Ã°£ 10-10 GBR A 12:10~12:30 TBD Aikou Okamoto(The Jikei University School of Medicine)
±³À°½Ã°£ 10-10 GBR A 13:00~13:15 Radical trachelectomy for young patients with early cervical cancer: the past and the future Jin Li(Fudan University Shanghai Cancer Center)
±³À°½Ã°£ 10-10 GBR A 13:15~13:30 Fertility preserving treatment of early stage endometrial cancer Xiaojun Chen(Hospital of Fudan University)
±³À°½Ã°£ 10-10 GBR A 13:30~13:45 Fertility preservation in early stage epithelial ovarian cancer Hiroaki Kajiyama(Nagoya University)
±³À°½Ã°£ 10-10 GBR A 13:45~14:00 Fertility preservation for female cancer patients Yutaka Osuga(The University of Tokyo)
±³À°½Ã°£ 10-10 204-205 13:00~13:15 Imaging study before cytoreductive surgery Byung Kwan Park(Samsung Medical Center)
±³À°½Ã°£ 10-10 204-205 13:15~13:30 Imaging follow up strategy of ovarian cancer Jeong Yeon Cho(Seoul National University Hospital & Seoul National University College of Medicine)
±³À°½Ã°£ 10-10 204-205 13:30~13:45 Functional Imaging of ovarian cancer Dae Chul Jung(Yonsei University)
±³À°½Ã°£ 10-10 204-205 13:45~14:00 Response evaluation: RECIST & iRECIST on imaging Sung Yoon Park(Samsung Seoul Hospital)
±³À°½Ã°£ 10-10 206-207 13:00~13:20 Ethical review of the research project Yawana Tanapat(Bumrungrad International Hospital)
±³À°½Ã°£ 10-10 206-207 13:20~13:40 Tips for success as a clinical investigator Soyi Lim(Gachon University University Gil Medical Center)
±³À°½Ã°£ 10-10 206-207 13:40~14:00 Transparency in medical writing Seung-Hyuk Shim(Konkuk University)
±³À°½Ã°£ 10-10 GBR A 14:05~14:20 Post chemotherapy quality of life in developing country Hariyono Winarto(Universitas Indonesia)
±³À°½Ã°£ 10-10 GBR A 14:20~14:35 Hypersensitivity reactions to carboplatin and paclitaxel: management and oncologic outcomes Suwanit Therasakvichya(Siriraj Hospital, Mahidol University)
±³À°½Ã°£ 10-10 GBR A 14:35~14:50 Hospice care by specialist palliative care team Yoon Jung Chang(National Cancer Center)
±³À°½Ã°£ 10-10 GBR A 14:50~15:05 Pain control in patients with advanced stage cancer Seyoung Seo(Asan Medical Center)
±³À°½Ã°£ 10-10 206-207 14:05~14:15 Bevacizumab maintenance therapy extended the overall survival for the histopathological mesenchymal transition type of high-grade serous ovarian carcinoma. Kentaro Ishida(Nagahama Red Cross Hospital)
±³À°½Ã°£ 10-10 206-207 14:15~14:25 Additional chemotherapy in epithelial ovarian cancer with residual disease after six cycles of postoperative adjuvant chemotherapy Se Ik Kim(Seoul National University College of Medicine)
±³À°½Ã°£ 10-10 206-207 14:25~14:35 Preliminary experience of hyperthermic intraperitoneal chemotherapy after debulking surgery for ovarian cancer Wei-Chun Chen(Chang Gung Memorial Hospital of Linkou Branch)
±³À°½Ã°£ 10-10 206-207 14:35~14:45 Enhanced chemotherapy effects on gynecological cancers by using the combination of lipid bubble and ultrasound Kohei Yamaguchi(The University of Tokyo)
±³À°½Ã°£ 10-10 206-207 14:45~14:55 Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: a promising drug delivery system for ovarian cancer Hyeji Jeon(Soonchunhyang university Cheonan hospital)
±³À°½Ã°£ 10-10 206-207 14:55~15:05 The influence of depression on health utility value in patients with gynecologic cancer : A comparison with physical symptoms and performance status Ye Lee Yu(National Cancer Center)
±³À°½Ã°£ 10-10 204-205 14:05~14:20 Surgical technique : radical upper abdominal dissection/resection Suk-Joon Chang(Ajou University School of Medicine)
±³À°½Ã°£ 10-10 204-205 14:20~14:35 Surgical technique : radical pelvic dissection/resection Kazuyoshi Kato(Tokyo Medical University)
±³À°½Ã°£ 10-10 204-205 14:35~14:50 MSKCC resectability score and selection criteria for primary debulking surgery Dennis Chi(Memorial Sloan Kettering Cancer Center)
±³À°½Ã°£ 10-10 204-205 14:50~15:05 Role of lymphadenectomy in ovarian cancer Jianqing Zhu(Zhejiang Cancer Hospital)